Olezarsen for Managing Severe Hypertriglyceridemia and Pancreatitis Risk

Journal:

The New England Journal of Medicine

Published:

2025-11-09

DOI:

10.1056/nejmoa2512761

Affiliations:

27

Authors:

31

Go to article

Institutions	Authors	Share
Ionis Pharmaceuticals, United States of America (USA)	6.500000	0.21
Brigham and Women's Hospital (BWH), United States of America (USA)	5.333333	0.17
Harvard Medical School (HMS), United States of America (USA)	3.500000	0.11
Copenhagen University Hospital (CUH), Denmark	1.000000	0.03
Lyon University Hospital (HCL), France	1.000000	0.03
University of Cape Town (UCT), South Africa	1.000000	0.03
Amsterdam UMC, Location AMC, Netherlands	1.000000	0.03
University Hospital Tsaritsa Yoanna-ISUL, Bulgaria	1.000000	0.03
Washington University in St. Louis (WUSTL), United States of America (USA)	1.000000	0.03
Monash University, Australia	1.000000	0.03
Shin Kong Wu Ho-Su Memorial Hospital, Taiwan	1.000000	0.03
Charles University (CU), Czech Republic	1.000000	0.03
Medical University of Lodz (MUL), Poland	1.000000	0.03
Chaim Sheba Medical Center at Tel HaShomer, Israel	0.500000	0.02
Tel Aviv University (TAU), Israel	0.500000	0.02
ECOGENE-21 Biocluster, Canada	0.500000	0.02
Central Hospital of Northern Pest - Military Hospital, Hungary	0.500000	0.02
Semmelweis University (SE), Hungary	0.500000	0.02
University of California, San Diego (UC San Diego), United States of America (USA)	0.500000	0.02
University of Montreal (UdeM), Canada	0.500000	0.02
Hospital Moinhos de Vento, Brazil	0.500000	0.02
Biomedical Research Networking Centers (CIBER), Spain	0.333333	0.01
Cardiovascular Research Foundation for Health Prevention and Innovation (FICSI), Spain	0.333333	0.01
Yale University, United States of America (USA)	0.333333	0.01
University of Vic - Central University of Catalonia (UVic-UCC), Spain	0.333333	0.01
VA Connecticut Healthcare System, United States of America (USA)	0.333333	0.01

Interested in Medical Biotechnology?